Physician profile
Michael Sclafani
NPI 1366421703
$966.51
in general payments reported to CMS, 2019-2025
15 companies · $62.41 in 2025
The $62.41 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $61.81 · 2021: $54.59 · 2022: $63.59 · 2023: $174 · 2024: $369 · 2025: $62.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $157.42 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Miach Orthopaedics, INC. | $135.15 | 2024 | |
| Ferring Pharmaceuticals INC. | $122.97 | 2019-2024 | Euflexxa |
| Bioventus LLC | $114.62 | 2019-2025 | Durolane |
| Depuy Synthes Sales INC. | $114.04 | 2019-2025 | Orthovisc |
| Stryker Corporation | $83.69 | 2024 | Inspace |
| Novo Nordisk INC | $43.75 | 2019 | |
| Pacira Therapeutics, INC. | $42.62 | 2019-2021 | |
| Treace Medical Concepts, INC. | $34.76 | 2022 | |
| Abbvie INC. | $33.17 | 2024 | |
| Sanofi-Aventis U.S. LLC | $28.97 | 2019-2022 | |
| Nevro Corp. | $22.59 | 2024 | Senza |
| Seapearl East, INC | $13.55 | 2025 | |
| Heron Therapeutics, INC. | $11.04 | 2021 | |
| Heraeus Medical, LLC. | $8.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sclafani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.